(Q42263068)

19 October 2017

Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients (English)

1 reference

19 October 2017

1 reference

1 reference

1 reference

1

Ahmed A Al-Qahtani

1 reference

19 October 2017

8

Nisreen Z Khalaf

1 reference

19 October 2017

4

Faisal M Sanai

1 reference

19 October 2017

3

Ayman A Abdo

1 reference

19 October 2017

5

Waleed K Al-Hamoudi

1 reference

19 October 2017

Mashael R Al-Anazi

2

1 reference

19 October 2017

Khalid A Alswat

6

1 reference

19 October 2017

Hamad I Al-Ashgar

7

1 reference

19 October 2017

Nisha A Viswan

9

1 reference

19 October 2017

Mohammed N Al Ahdal

10

1 reference

19 October 2017

language of work or name

1 reference

20 November 2013

1 reference

19 October 2017

1 reference

19 October 2017

34

1 reference

19 October 2017

7

1 reference

19 October 2017

e208-16

1 reference

Hepatitis B Virus Infection

19 October 2017

1 reference

The discovery of the hepatitis viruses

21 January 2018

1 reference

Epidemiology of hepatitis B and C viruses: a global overview

21 January 2018

1 reference

Management of hepatitis B: 2000--summary of a workshop

21 January 2018

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus

21 January 2018

1 reference

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

21 January 2018

1 reference

The natural history of chronic HBV infection and geographical differences

21 January 2018

1 reference

Associations of hepatitis B surface antigenemia with HLA locus B specificities

21 January 2018

1 reference

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development

21 January 2018

1 reference

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

21 January 2018

1 reference

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers

21 January 2018

1 reference

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean

21 January 2018

1 reference

Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients.

21 January 2018

1 reference

Tumour necrosis factor-α-857T allele reduces the risk of hepatitis B virus infection in an Asian population

21 January 2018

1 reference

A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population

21 January 2018

1 reference

Interferon lambdas: the next cytokine storm

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

Interferon-lambda and therapy for chronic hepatitis C virus infection

21 January 2018

1 reference

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

21 January 2018

1 reference

Type III IFNs: new layers of complexity in innate antiviral immunity

21 January 2018

1 reference

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

21 January 2018

1 reference

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death

21 January 2018

1 reference

Genetics of infectious diseases

21 January 2018

1 reference

Understanding the host genetics of chronic hepatitis B and C.

21 January 2018

1 reference

Host genomics and HCV treatment response.

21 January 2018

1 reference

Innate immune recognition of viral infection

21 January 2018

1 reference

Biology and significance of the JAK/STAT signalling pathways

21 January 2018

1 reference

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

21 January 2018

1 reference

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

21 January 2018

1 reference

Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population

21 January 2018

1 reference

Interferon-lambda serum levels in hepatitis C.

21 January 2018

1 reference

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.

21 January 2018

1 reference

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

21 January 2018

1 reference

IL28B and the control of hepatitis C virus infection

21 January 2018

1 reference

IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection

21 January 2018

1 reference

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

21 January 2018

1 reference

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12347

1 reference

19 October 2017

1 reference